लोड हो रहा है...
Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers
Over the past few years, multiple immune checkpoint blockers (ICBs) have achieved unprecedented clinical success and have been approved by regulatory agencies for the treatment of an increasing number of malignancies. However, only a limited fraction of patients responds to ICBs employed as a standa...
में बचाया:
| में प्रकाशित: | Semin Cancer Biol |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6004231/ https://ncbi.nlm.nih.gov/pubmed/29258856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2017.12.007 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|